In the biotech world, you can’t see everything
The film's title lands differently depending on which seat you're in. For a jury it was a fraud, for auditors it was a nightmare, and for Elizabeth Holmes it was probably the story she rehearsed in the mirror every morning. I like that a documentary about this particular scandal is willing to ask what "seeing" even means in a field whose whole pitch is peering into something invisible, like a single drop of blood.
I went in expecting the usual true-crime beats, but the film seems more interested in the space between what the technology promised and what the eyes actually showed. That's a deeper cut. It makes you wonder how many other Theranos-sized blind spots are sitting in plain sight, not because anyone is lying but because nobody can quite bring themselves to look too hard. The science is hard enough, but the human reluctance to say "I don't know" might be harder.
I'd want to hear more from the engineers who actually ran the machines. They're the ones who saw the gap first, in the wonky numbers and the repeated failures. If the documentary gives them room to talk, it'll offer more than any headline about collapsing valuations ever did.